Lung Cancer Screening
An Unmet Medical Need
More Americans (160,000) will die from lung cancer this year than from breast, prostate, and colorectal cancer combined (American Cancer Society).
Will die from lung cancer this year worldwide
Current 5 year
The lack of an early detection method is a key factor contributing to this low rate. The current methods of diagnosis are proven to be ineffective and expensive.
With our detection test via breath analysis, we can target at risk groups and have a much higher chance to pinpoint the cancer early.
5 year survival rate
with early detection:
In 2018, Picomole worked with the American Society of Clinical Oncology (ASCO) to publish an abstract validating the use of IR absorption measurements for the detection of non small cell lung cancer. Read the abstract
In 2020, Picomole worked with the University of New Brunswick (UNB) to publish an abstract on the identification of lung cancer biomarkers.
Read the abstract
View the poster